Claims peptides such as GHK-Cu, BPC-157 and TB-500 can help regenerate and repair tissue and calm inflammation are based on a handful of laboratory studies in cells or animals, not humans
GLP-1 receptor agonists like semaglutide and tirzepatide have changed the game in obesity management, helping patients lose significant amounts of weight
Ethics declarations Conflicts of Interest T
Side effects were most frequently cited by our surveyed members as the worst part of taking their medication, followed by the discomfort of injections
None of its four components, GHK-Cu, BPC-157, TB-500, or KPV, have completed clinical trials for any approved indication
Do insurance appeals actually work